摘要
目的考察丹参酮ⅡA静脉乳剂在小鼠体内的药动学和组织分布特征。方法血浆和组织匀浆液经沉淀蛋白,以乙腈-0.01mol·L-1枸橼酸水溶液(78:22)为流动相,经DiamonsilTM C18(4.6mm×150mm,5μm)分离,检测波长为270nm,吉非罗奇为内标,进行色谱分析。结果小鼠iv丹参酮ⅡA静脉乳剂20mg·kg-1后,药-时曲线符合二室模型,其主要药动学参数为:t1/2β2.48h,Vd16.23L·kg-1,CL 4.54L·h-1·kg-1,AUC0-∞ 4.404mg·h·L-1。组织分布结果表明,在15min时,肺脏浓度最高,其次是脑、心脏、脾脏,肝脏和肾脏最低,随后浓度下降迅速,在1.5~4.0h内长期保持低浓度。结论丹参酮ⅡA静脉乳剂体内分布迅速,组织分布广泛,肺中浓度最高,且能通过血脑屏障,与丹参酮ⅡA磺酸钠在体内的组织分布有差异。
Abstract
OBJECTIVE To investigate the pharmacokinetics and tissue distribution of TSⅡA emulsion.METHODS After the plasma protein and tissue homogenate were precipitated,the analysis was conducted on a DiamonsilTM C18(4.6 mm×150 mm,5 μm)column with mobile phase consisting of acetonitrile-0.01 mol·L-1 Citric Acid solution(78∶22).Gemfibrozil was internal standard.The detective wavelength was 270 nm.RESULTS The concentration-time curve of TSⅡA emulsion was discribed by a two-compartment model.The main pharmacokinetic parameters were as follows:t1/2β 2.48 h,Vd 16.23 L·kg-1,CL 4.54 L·h-1·kg-1,AUC0-∞ 4.404 mg·h·L-1.In tissue distribution,the TS ⅡA concentration in the lung was the highest and those in the brain,heart,spleen,liver and kidney was lower sequentially.Then concentration descended rapidly,remaining at low level from 1.5 h to 4 h.CONCLUSION TSⅡA emulsion belongs to a short-half-life drug,distributed quickly and extensively.It has the ability to permeate blood brain barrier.It is different from TSⅡA sulfonic acid sodium in the tissue distribution.
关键词
丹参酮ⅡA /
药动学 /
组织分布 /
反相高效液相色谱法
{{custom_keyword}} /
Key words
TSⅡA /
pharmacokinetics /
tissue distribution /
RP-HPLC
{{custom_keyword}} /
周娟;肇丽梅;孙亚欣;何晓静.
丹参酮ⅡA静脉乳剂在小鼠体内的药动学和组织分布研究[J]. 中国药学杂志, 2008, 43(11): 858-861
ZHOU Jun;ZHO Li-mei;SUN Y-xin;HE Xio-jing.
Investigation on Pharmacokinetics and Tissue Distribution of TSⅡA Emulsion in Mice [J]. Chinese Pharmaceutical Journal, 2008, 43(11): 858-861
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WANG Y S,DENG W L,XUE C S. Pharmacology and Applycation of Chinese Medicine(中药药理与应用)[M] .2nd Ed. Beijing:People’s Medical Publishing House,1998:190.
[2] YE L B,XI T,CHEN F,et al. Protective effect of tanshinoneⅡA against focal cerebral ischemia reperfusion injury in rats[J] .J China Pharm Univ(中国药科大学学报),2004,35(3):267-270.
[3] SHAO H S,JING X N,YING L Q. Distribution and metabolism of 3H-tanshinoneⅡA sulphonate in rats[J] .Nuclear Techniques(核技术),1981,5:55-57.
[4] WANG D D,CHEN J M,ZHANG Y M. The progress of research on therapeutic intravenous emulsion[J] .Pharm Care Res(药学服务与研究),2005,5(2):157-159.
[5] LI L,JIANG X H,YUAN Y,et al. Pharmacokinetics of alcohol extract of Radix Salviae Miltiorrhiaze in rat in vivo[J] .Chin Tradit Herb Drugs(中草药),2005,36(10):1480-1482.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}